Roche Fuzeon WAC
Executive Summary
Wholesale acquisition cost of Roche/Trimeris' HIV agent Fuzeon (enfuvirtide) will be "just under $20,000 for one year's supply," the companies said. Roche Global Pharmaceutical Head William Burns said a settlement has been reached with state AIDS Drug Assistance Programs but "it is on terms that we are not releasing publicly." Roche used its broad antiretrovial portfolio as leverage in price negotiations with state ADAPs (1"The Pink Sheet" March 24, p. 35)...